Polymorphism C677T MTHFR and Folate Intake in Inflammatory Biomarkers
NCT ID: NCT03186196
Last Updated: 2017-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2016-08-01
2017-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Thus, a diet containing folate as a main antioxidant nutrient, could reduce not only the oxidative stress, but also has many others benefits for individuals with this genetic alteration, like the anti-inflammatory function, which could help restore the altered serum levels and minimizing or avoiding the development of future diseases.
The aim of this study was to evaluate the influence of the C677T polymorphism of the MTHFR gene and the effect of a diet containing folate in the inflammatory markers levels, such as homocysteine, Tumor Necrosis Factor alpha (TNF-α) and interleukins in women with overweight or obesity. This is an intervention study, double-blind, held in a city in northeastern Brazil, with a sample of 48 adult women (20-59 years old) with BMI among 26.19 kg / m² and 49.64 kg / m². In which we evaluated the TNF-α levels, Interleukins 1β, Interleukin 6, Interleukin 8, Interleukin 12p70, Interleukin 10, homocysteine, folic acid and in addition to these markers evaluation, were made the genotyping for the C677T polymorphism in the MTHFR gene and the food consumption assessment by the 24 hour dietary recall (24HR). For the intervention, the sample was divided by randomization into two groups, each one with 24 indivuals, receiving daily during 8 weeks, a salad with 300g vegetables containing 191 ug of folate for group 1 and 90 ug for group 2.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Polymorphism C677T MTHFR and Effects of Folate Intake
NCT02953522
Effect of Folic Acid on Primary Folate Forms in Relation to MTHFR
NCT01105351
Folic Acid Supplementation in Women of Child Bearing Age
NCT01841658
Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in COVID-19patients
NCT05679414
5-methyltetrahydrofolate Survival and Inflammation in ESRD Patients
NCT00626223
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After the selection of individuals from the sample of adults who participated in the II DISANDNT / JP and considering the inclusion criteria and genotyping of the C677T polymorphism in the MTHFR gene, they were invited to participate.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Diet with 191 mcg/day of Folate
Diet containing Folate
Group 2
Diet containing 90 mcg / day of Folate
Diet containing Folate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diet containing Folate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals of different socioeconomic conditions
* Users or not drugs
* Cognitive state preserved and accept participate
Exclusion Criteria
* Users drugs known to interfere with the metabolism of folic acid (the last 3 months), as prednisone, hydrocortisone, dexamethasone, chloramphenicol, acetylsalicylic acid
* Multivitamin supplement users, minerals, appetite suppressants and steroids
* Individuals with chronic diseases with influence on the endocrine and metabolic system
* Pregnant or planning to become pregnant during the study period
20 Years
59 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Paraíba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jéssica Vanessa de Carvalho Lisboa
Nutritionist and Master Degree Student of Science of Nutrition
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria José de Carvalho Costa, PhD
Role: STUDY_DIRECTOR
UFPB
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FUParaíbaaa
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.